|
[1]
|
Friedberg, E.C. (2003) DNA damage and repair. Nature, 421, 436-440. doi:10.1038/nature01408
|
|
[2]
|
Nowell, P.C. (2002) Tumor progression: A brief historical perspective. Seminars in Cancer Biology, 12, 261-266.
doi:10.1016/S1044-579X(02)00012-3
|
|
[3]
|
Maley, C.C., Galipeau, P.C., Li, X.H., et al. (2004) Selectively advantageous mutations and hitchhikers in neoplasms: p16 lesions are selected in Barrett’s esophagus. Cancer Research, 64, 3414-3427.
doi:10.1158/0008-5472.CAN-03-3249
|
|
[4]
|
Knudson, A.G. (2002) Cancer genetics. American Journal of Medical Genetics, 111, 96-102.
doi:10.1002/ajmg.10320
|
|
[5]
|
Fearon, E.R. and Vogelstein, B. (1990) A genetic model for colorectal tumorigenesis. Cell, 61, 759-767.
doi:10.1016/0092-8674(90)90186-I
|
|
[6]
|
Lengauer, C., Kinzler, K.W. and Vogelstein, B. (1998) Genetic instabilities in human cancers. Nature, 396, 643-649. doi:10.1038/25292
|
|
[7]
|
Vogelstein, B. and Kinzler, K.W. (1996) Lessons from hereditary colorectal cancer. Cell, 87, 159-170.
doi:10.1016/S0092-8674(00)81333-1
|
|
[8]
|
Foulkes, W.D. (1995) A tale of four syndromes: Familial adenomatous polyposis, Gardner syndrome, attenuated APC and Turcot syndrome. Monthly Journal of the Association of Physicians, 88, 853-863.
|
|
[9]
|
Soravia, C., Berk, T., Madlensky, L., et al. (1998) Genotype-phenotype correlations in attenuated adenomatous polyposis coli. American Journal of Human Genetics, 62, 1290-1301. doi:10.1086/301883
|
|
[10]
|
Miyaki, M., Konishi, M., Kikuchiyanoshita, R., et al. (1994) Characteristics of somatic mutation of the adenomatous polyposis-coli gene in colorectal tumors. Cancer Research, 54, 3011-3020.
|
|
[11]
|
Chung, D.C. (2000) The genetic basis of colorectal cancer: Insights into critical pathways of tumorigenesis. Gastroenterology, 119, 854-865.
doi:10.1053/gast.2000.16507
|
|
[12]
|
Powell, S.M., Zilz, N., Beazer-Barclay, Y., et al. (1992) APC mutations occur early during colorectal tumorigenesis. Nature, 359, 235-237. doi:10.1038/359235a0
|
|
[13]
|
Vogelstein, B., Fearon, E.R., Hamilton, S.R., et al. (1988) Genetic alterations during colorectal-tumor development. New England Journal of Medicine, 319, 525-532.
doi:10.1056/NEJM198809013190901
|
|
[14]
|
Bokoch, G.M. and Der, C.J. (1993) Emerging concepts in the ras superfamily of Gtp-binding proteins. FASEB Journal, 7, 750-759
|
|
[15]
|
Arber, N., Shapira, I., Ratan, J., et al. (2000) Activation of c-K-ras mutations in human gastrointestinal tumors. Gastroenterology, 118, 1045-1050.
doi:10.1016/S0016-5085(00)70357-X
|
|
[16]
|
Bos, J.L., Fearon, E.R., Hamilton, S.R., et al. (1987) Prevalence of ras gene-mutations in human colorectal cancers. Nature, 327, 293-297. doi:10.1038/327293a0
|
|
[17]
|
Tsao, J.I. and Shibata, D. (1994) Further evidence that one of the earliest alterations in colorectal carcinogenesis involves APC. American Journal of Pathology, 145, 531-534.
|
|
[18]
|
Ochiai, A. and Hirohashi, S. (1997) Multiple genetic alterations in gastric cancer. Oxford University Press, New York.
|
|
[19]
|
Somasundaram, K. and El-Deiry, W.S. (2000) Tumor suppressor P53: Regulation and function. Frontiers in Bioscience, 5, D424-D437. doi:10.2741/Somasund
|
|
[20]
|
Ohue, M., Tomita, N., Monden, T., et al. (1994) A frequent alteration of P53 gene in carcinoma in adenoma of colon. Cancer Research, 54, 4798-4804.
|
|
[21]
|
Kikuchiyanoshita, R., Konishi, M., Ito, S., et al. (1992) Genetic changes of both P53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and nonfamilial adenomatous polyposis patients. Cancer Research, 52, 3965-3971.
|
|
[22]
|
Lane, D.P. (1993) Cancer—A death in the life of P53. Nature, 362, 786-787. doi:10.1038/362786a0
|
|
[23]
|
Levine, A.J. (1997) P53, the cellular gatekeeper for growth and division. Cell, 88, 323-331
doi:10.1016/S0092-8674(00)81871-1
|
|
[24]
|
Howe, J.R. and Guillem, J.G. (1997) The genetics of colorectal cancer. Surgical Clinics of North America, 77, 175-195. doi:10.1016/S0039-6109(05)70538-7
|
|
[25]
|
Fearon, E.R., Cho, K.R., Nigro, J.M., et al. (1990) Identification of a chromosome-18q gene that is altered in colorectal cancers. Science, 247, 49-56.
doi:10.1126/science.2294591
|
|
[26]
|
Bernet, A. and Mehlen, P. (2007) Dependence receptors: When apoptosis controls tumor progression. Bull Cancer, 98, E12-E17.
|
|
[27]
|
Breivik, J. and Gaudernack, G. (1999) Genomic instability, DNA methylation, and natural selection in colorectal carcinogenesis. Seminars in Cancer Biology, 9, 245-254. doi:10.1006/scbi.1999.0123
|
|
[28]
|
Herman, J.G., Umar, A., Polyak, K., et al. (1998) Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proceedings of the National Academy of Sciences of the United States of America, 95, 6870-6875. doi:10.1073/pnas.95.12.6870
|
|
[29]
|
Kane, M.F., Loda, M., Gaida, G.M., et al. (1997) Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Research, 57, 808-811.
|
|
[30]
|
Veigl, M.L., Kasturi, L., Olechnowicz, J., et al. (1998) Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. Proceedings of the National Academy of Sciences of the United States of America, 95, 8698-8702.
doi:10.1073/pnas.95.15.8698
|
|
[31]
|
Ramsahoye, B.H., Davies, C.S. and Mills, K.I. (1996) DNA methylation: Biology and significance. Blood Reviews, 10, 249-261. doi:10.1016/S0268-960X(96)90009-0
|
|
[32]
|
Monk, M. (1995) Epigenetic programming of differential gene-expression in development and evolution. Developmental Genetics, 17, 188-197.
doi:10.1002/dvg.1020170303
|
|
[33]
|
Feil, R. and Kelsey, G. (1997) Genomic imprinting: A chromatin connection. American Journal of Human Genetics, 61, 1213-1219. doi:10.1086/301655
|
|
[34]
|
Barbacid, M. (1987) Ras genes. Annual Review of Biochemistry, 56, 779-827.
doi:10.1146/annurev.bi.56.070187.004023
|
|
[35]
|
Jones, P.A. and Laird, P.W. (1999) Cancer epigenetics comes of age. Nature Genet, 21, 163-167.
doi:10.1038/5947
|
|
[36]
|
Grady, W.M., Willis, J., Guilford, P.J., et al. (2000) Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nature Genet, 26, 16-17. doi:10.1038/79120
|
|
[37]
|
Baylin, S.B. and Herman J.G. (2000) DNA hypermethylation in tumorigenesis: Epigenetics joins genetics. Trends in Genetics, 16, 168-174.
doi:10.1016/S0168-9525(99)01971-X
|
|
[38]
|
Herman, J.G., Merlo, A. Mao, L., et al. (1995) Inactivation of the Cdkn2/P16/Mts1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Research, 55, 4525-4530.
|
|
[39]
|
Toyota, M., Ahuja, N., Ohe-Toyota, M., et al. (1999) CpG island methylator phenotype in colorectal cancer. Proceedings of the National Academy of Sciences of the United States of America, 96, 8681-8686.
doi:10.1073/pnas.96.15.8681
|
|
[40]
|
Toyota, M., Ho, C., Ahuja, N., et al. (1999) Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Research, 59, 2307-2312.
|
|
[41]
|
Ivanovich, J.L., Read, T.E., Ciske, D.J., et al. (1999) A practical approach to familial and hereditary colorectal cancer. American Journal of Medicine, 107, 68-77.
doi:10.1016/S0002-9343(99)00168-0
|
|
[42]
|
Watson, P. and Lynch, H.T. (1994) The Tumor Spectrum in Hnpcc. Anticancer Research, 14, 1635-1639.
|
|
[43]
|
Aarnio, M., Sankila, R., Pukkala, E., et al. (1999) Cancer risk in mutation carriers of DNA-mismatch-repair genes. International Journal of Cancer, 81, 214-218.
doi:10.1002/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.0.CO;2-L
|
|
[44]
|
Smyrk, T.C., Watson, P., Kaul, K., et al. (2001) Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma. Cancer, 91, 2417-2422.
doi:10.1002/1097-0142(20010615)91:12<2417::AID-CNCR1276>3.0.CO;2-U
|
|
[45]
|
Alexander, J., Watanabe, T., Wu, T.T., et al. (2001) Histopathological identification of colon cancer with microsatellite instability. American Journal of Pathology, 158, 527-535. doi:10.1016/S0002-9440(10)63994-6
|
|
[46]
|
Jass, J.R., Young, J. and Leggett, B.A. (2002) Evolution of colorectal cancer: Change of pace and change of direction. Journal of Gastroenterology and Hepatology, 17, 17-26. doi:10.1046/j.1440-1746.2002.02635.x
|
|
[47]
|
Galiatsatos, P. and Foulkes, W.D. (2006) Familial adenomatous polyposis. American Journal of Gastroenterology, 101, 385-398.
doi:10.1111/j.1572-0241.2006.00375.x
|
|
[48]
|
Talbot, I.C., Burt, R., Jarvinen, H., et al. (2000) Familial adenomatous polyposis. In: Hamilton, S.R. and Aaltonen, L.A., Eds., WHO Classification of Tumours, Pathology and Genetics of Tumours of the Digestive System. IARC Press, Lyon, 120-125.
|
|
[49]
|
Fallen, T., Wilson, M., Morlan, B., et al. (2006) Desmoid tumors—A characterization of patients seen at Mayo Clinic 1976-1999. Familial Cancer, 5, 191-194.
doi:10.1007/s10689-005-5959-5
|
|
[50]
|
Tomoda, C., Miyauchi, A., Uruno, T., et al. (2004) Cribriform-morular variant of papillary thyroid carcinoma: Clue to early detection of familial adenomatous polyposis-associated colon cancer. World Journal of Surgery, 28, 886-889. doi:10.1007/s00268-004-7475-4
|
|
[51]
|
Cetta, F., Montalto, G., Gori, M., et al. (2000) Germline mutations of the APC gene in patients with familial adenomatous polyposis-associated thyroid carcinoma: Results from a European cooperative study. Journal of Clinical Endocrinology & Metabolism, 85, 286-292.
doi:10.1210/jc.85.1.286
|
|
[52]
|
Aretz, S., Koch, A., Uhlhaas, S., et al. (2006) Should children at risk for familial adenomatous polyposis be screened for hepatoblastoma and children with apparently sporadic hepatoblastoma be screened for APC germline mutations? Pediatric Blood & Cancer, 47, 811-818.
doi:10.1002/pbc.20698
|
|
[53]
|
Munitz, M.I. (1986) Polyposis syndromes. In: Ott, D.J. and Wu, W.C., Eds., Polypoid Diseases of the Colon, Urban & Schwarzenberg, Baltimore, 43-61.
|
|
[54]
|
Dachman, A.H., Buck, J.L., Burke, A.P., et al. (1989) Cronkhite-Canada syndrome: Radiologic features. Gastrointestinal Radiology, 14, 285-290.
doi:10.1007/BF01889219
|
|
[55]
|
Gorlin, R.J., Cohen, M.M., Condon, L.M., et al. (1992) Bannayan-Riley-Ruvalcaba syndrome. American Journal of Medical Genetics, 44, 307-314.
doi:10.1002/ajmg.1320440309
|
|
[56]
|
Salem, O.S. and Steck, W.D. (1983) Cowdens disease (multiple hamartoma and neoplasia syndrome). A casereport and review of the English-literature. Journal of the American Academy of Dermatology, 8, 686-696.
doi:10.1016/S0190-9622(83)70081-2
|
|
[57]
|
Peutz, J.L.A. (1921) Over een zeer merkwaardige, gecombineerde familiaire polyposis van de slijmvliezen van den tractus intestinalis met die van de neuskeelholte en gepaard met eigenaardige pigmentaties van huiden slijmvliezen. Ned Maandschr v Geneesk, 10, 134-146.
|
|
[58]
|
Jeghers, H., McKusick, V.A. and Katz, K.H. (1949) Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits—A syndrome of diagnostic significance. New England Journal of Medicine, 241, 993-1005. doi:10.1056/NEJM194912222412501
|
|
[59]
|
Tomlinson, I.P.M. and Houlston, R.S. (1997) PeutzJeghers syndrome. Journal of Medical Genetics, 34, 1007-1011. doi:10.1136/jmg.34.12.1007
|
|
[60]
|
Buck, J.L., Harned, R.K., Lichtenstein, J.E., et al. (1992) Peutz-Jeghers syndrome. Radiographics, 12, 365-378.
|
|
[61]
|
Spigelman, A.D. and Phillips, R.K.S. (1994) Peutz-Jeghers syndrome. In: Phillips, R.K.S., Spigelman, A.D. and Thomson, J.P.S., Eds., Familial Adenomatous Polyposis and Other Polyposis Syndromes, Edward Arnold, London, 188-202.
|
|
[62]
|
Wang, Z.J., Ellis, I., Zauber, P., et al. (1999) Allelic imbalance at the LKB1 (STK11) locus in tumours from patients with Peutz-Jeghers’ syndrome provides evidence for a hamartoma-(adenoma)-carcinoma sequence. Journal of Pathology, 188, 9-13.
doi:10.1002/(SICI)1096-9896(199905)188:1<9::AID-PATH326>3.0.CO;2-E
|
|
[63]
|
Aaltonen, L.A. (2000) Hereditary intestinal cancer. Seminars in Cancer Biology, 10, 289-298.
doi:10.1006/scbi.2000.0148
|
|
[64]
|
McColl, I., Bussey, H.J.R., Veale, A.M.O., et al. (1964) Juvenile polyposis coli. Proceedings of the Royal Society of Medicine-London, 57, 896-897.
|
|
[65]
|
Houlston, R., Bevan, S., Williams, A., et al. (1998) Mutations in DPC4 (SMAD4) cause juvenile polyposis syndrome, but only account for a minority of cases. Human Molecular Genetics, 7, 1907-1912.
doi:10.1093/hmg/7.12.1907
|
|
[66]
|
Howe, J.R., Bair, J.L., Sayed, M.G., et al. (2001) Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nature Genet, 28, 184-187. doi:10.1038/88919
|
|
[67]
|
Sayed, M.G., Ahmed, A.F. Ringold, J.R. et al. (2002) Germline SMAD4 or BMPR1A mutations and phenotype of juvenile polyposis. Annals of Surgical Oncology, 9, 901-906. doi:10.1007/BF02557528
|
|
[68]
|
Popat, S. and Houlston, R.S. (2005) A systematic review and meta-analysis of the relationship between chromosome 18q genotype, DCC status and colorectal cancer prognosis. European Journal of Cancer, 41, 2060-2070.
doi:10.1016/j.ejca.2005.04.039
|
|
[69]
|
Boland, C.R., Thibodeau, S.N. Hamilton, S.R., et al. (1998) A national cancer institute workshop on microsatellite instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Research, 58, 5248-5257.
|
|
[70]
|
Huang, J., Papadopoulos, N., McKinley, A.J., et al. (1996) APC mutations in colorectal tumors with mismatch repair deficiency. Proceedings of the National Academy of Sciences of the United States of America, 93, 9049-9054.
doi:10.1073/pnas.93.17.9049
|
|
[71]
|
Konishi, M., Kikuchi-Yanoshita, R., Tanaka, K., et al. (1996) Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer. Gastroenterology, 111, 307-317.
doi:10.1053/gast.1996.v111.pm8690195
|
|
[72]
|
Miyaki, M., Iijima, T., Kimura, J., et al. (1999) Frequent mutation of ss-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer. Cancer Research, 59, 4506-4509.
|
|
[73]
|
Fujiwara, T., Stolker, J.M., Watanabe, T., et al. (1998) Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences. American Journal of Pathology, 153, 1063-1078.
doi:10.1016/S0002-9440(10)65651-9
|
|
[74]
|
Eshleman, J.R., Casey, G., Kochera, M.E., et al. (1998) Chromosome number and structure both are markedly stable in RER colorectal cancers and are not destabilized by mutation of p53. Oncogene, 17, 719-725.
doi:10.1038/sj.onc.1201986
|
|
[75]
|
Yamamoto, H., Sawai, H. and Perucho M. (1997) Frame-shift somatic mutations in gastrointestinal cancer of the microsatellite mutator phenotype. Cancer Research, 57, 4420-4426.
|
|
[76]
|
Perucho, M. (1996) Cancer of the microsatellite mutator phenotype. Biological Chemistry, 377, 675-684.
|
|
[77]
|
Yamamoto, H., Sawai, H., Weber, T.K. et al. (1998) Somatic frameshift mutations in DNA mismatch repair and proapoptosis genes in hereditary nonpolyposis colorectal cancer. Cancer Research, 58, 997-1003.
|
|
[78]
|
Markowitz, S., Wang, J., Myeroff, L., et al. (1995) Inactivation of the type-II TGF-Beta receptor in colon-cancer cells with microsatellite instability. Science, 268, 1336-1338. doi:10.1126/science.7761852
|
|
[79]
|
Piao, Z., Fang, W., Malkhosyan, S., et al. (2000) Frequent frameshift mutations of RIZ in sporadic gastrointestinal and endometrial carcinomas with microsatellite instability. Cancer Research, 60, 4701-4704.
|
|
[80]
|
Mori, Y., Yin, J., Rashid, A., et al. (2001) Instabilotyping: Comprehensive identification of frameshift mutations caused by coding region microsatellite instability. Cancer Research, 61, 6046-6049.
|
|
[81]
|
Vasen, H.F.A., Watson, P., Mecklin, J.P., et al. (1999) New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the international collaborative group on HNPCC. Gastroenterology, 116, 1453-1456.
doi:10.1016/S0016-5085(99)70510-X
|
|
[82]
|
Vasen, H.F.A., Mecklin, J.P., Khan, P.M., et al. (1991) The international collaborative group on hereditary nonpolyposis colorectal cancer (ICG-HNPCC). Diseases of the Colon & Rectum, 34, 424-425.
doi:10.1007/BF02053699
|
|
[83]
|
Rodriguez Bigas, M.A., Boland, C.R., Hamilton, S.R., et al. (1997) A National Cancer Institute workshop on hereditary nonpolyposis colorectal cancer syndrome: Meeting highlights and Bethesda guidelines. Journal of the National Cancer Institute, 89, 1758-1762.
|
|
[84]
|
Umar, A., Boland, C.R., Terdiman, J.P., et al. (2004) Revised bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. Journal of the National Cancer Institute, 96, 261-268. doi:10.1093/jnci/djh034
|
|
[85]
|
Aaltonen, L.A., Salovaara, R., Kristo, P., et al. (1998) Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. New England Journal of Medicine, 338, 1481-1487.
doi:10.1056/NEJM199805213382101
|
|
[86]
|
Lynch, H.T. and de la Chapelle, A. (2003) Genomic medicine—Hereditary colorectal cancer. New England Journal of Medicine, 348, 919-932.
doi:10.1056/NEJMra012242
|
|
[87]
|
Gryfe, R., Kim, H. Hsieh, E.T.K., et al. (2000) Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. New England Journal of Medicine, 342, 69-77.
doi:10.1056/NEJM200001133420201
|
|
[88]
|
Popat, S., Hubner, R. and Houlston, R.S. (2005) Systematic review of microsatellite instability and colorectal cancer prognosis. Journal of Clinical Oncology, 23, 609-618. doi:10.1200/JCO.2005.01.086
|
|
[89]
|
Lanza, G., Gafa, R., Santini, A., et al. (2006) Immunohistochemical test for MLH1 and MSH2 expression predicts clinical outcome in stage II and III colorectal cancer patients. Journal of Clinical Oncology, 24, 2359-2367.
doi;10.1200/JCO.2005.03.2433
|
|
[90]
|
Carethers, J.M., Smith, E.J., Behling, C.A., et al. (2004) Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer. Gastroenterology, 126, 394-401. doi:10.1053/j.gastro.2003.12.023
|
|
[91]
|
Arnold, C.N., Goel, A. and Boland, C.R. (2003) Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines. International Journal of Cancer, 106, 66-73. doi:10.1002/ijc.11176
|
|
[92]
|
Ribic, C.M., Sargent, D.J., Moore, M.J., et al. (2003) Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. New England Journal of Medicine, 349, 247-257. doi:10.1056/NEJMoa022289
|